Weekly Dose of GenAI Adoption

This newsletter from Indy Sawhney discusses the critical challenges of scaling artificial intelligence within large organizations. The author emphasizes that successful AI transformation requires more than just financial investment or executive excitement; it demands internal leadership discipline and a robust execution infrastructure. By citing research on high failure rates for corporate changes, the text warns against the "messy middle" phase where projects often stall due to a lack of clear strategy and employee buy-in. To overcome these hurdles, the source suggests that leaders must build internal transformation muscles, such as dedicated project management offices and active AI councils. Ultimately, the newsletter argues that executives should lead by example by sharing their personal experiences and practical struggles with the technology to inspire authentic organizational adoption.

In this edition of his newsletter, Indy Sawhney addresses the critical challenges of implementing agentic AI within regulated industries. He argues that many organizations mistakenly prioritize building AI pilots before establishing the compliant infrastructure necessary for production. By failing to secure the proper data pipelines and governance environments first, companies often see their projects stall during the transition from demo to deployment. Sawhney describes this foundational work as a non-regrettable investment that serves as the essential "house" for all future AI agents. Ultimately, the source provides a strategic playbook for leaders to shift their focus toward building validated environments that ensure long-term scalability and security. This approach transforms the path to production from a complex maze into a streamlined, high-velocity process.

This newsletter from Indy Sawhney provides a strategic framework for calculating the Return on Investment (ROI) of agentic AI within the pharmaceutical industry. It emphasizes that traditional financial models often fail because they ignore the high program costs of regulated deployments and rely too heavily on minor labor savings. Instead, the text argues that the primary financial value of AI stems from timeline compression, which allows drugs to reach the market faster. To secure funding, leaders are encouraged to collaborate with CFOs and technical stakeholders to validate these assumptions with real production data. Ultimately, the source serves as a practical playbook for navigating the complex financial and regulatory realities of large-scale AI adoption.

This edition of the Weekly Dose of AI Adoption newsletter by Indy Sawhney focuses on accurately measuring the return on investment (ROI) for agentic AI systems. While several credible frameworks exist from leaders like Microsoft and Google, the author argues that they often rely on clean data inputs that most enterprises currently lack. A significant portion of the text highlights a "cost iceberg," warning that inference fees only represent a small fraction of the total expenses, while orchestration, governance, and human oversight account for the majority. To address these challenges, the author proposes a six-input floor model designed to provide a transparent and defensible financial baseline for stakeholders. Ultimately, the source serves as a strategic playbook for leaders to transition from speculative guessing to grounded, data-driven AI implementation.

This newsletter by Indy Sawhney outlines a strategic framework for accelerating AI adoption within large organizations by focusing on incremental sequencing. Rather than attempting massive transformations immediately, leaders are encouraged to begin with narrowly scoped, rule-based workflows that offer easily measurable results. Using biopharma data processing as a primary example, the text demonstrates how agentic AI can drastically reduce timelines and improve efficiency when applied to specific, bounded tasks. The source emphasizes a "Power of Three" operating model to maintain clear accountability between customers, technical teams, and builders. Ultimately, establishing credible baselines through individual use cases is presented as the only reliable way to earn the financial and organizational support required for large-scale integration.